{"id":"https://openalex.org/W4386466480","doi":"https://doi.org/10.1001/jamadermatol.2023.3003","title":"Cutaneous Adverse Events and Cancer Survival Prognosis With Immune Checkpoint Inhibitor Treatment","display_name":"Cutaneous Adverse Events and Cancer Survival Prognosis With Immune Checkpoint Inhibitor Treatment","publication_year":2023,"publication_date":"2023-09-06","ids":{"openalex":"https://openalex.org/W4386466480","doi":"https://doi.org/10.1001/jamadermatol.2023.3003","pmid":"https://pubmed.ncbi.nlm.nih.gov/37672255","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10483383"},"language":"en","primary_location":{"id":"doi:10.1001/jamadermatol.2023.3003","doi":"https://doi.org/10.1001/jamadermatol.2023.3003","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jamadermatol.2023.3003","pdf_url":null,"source":{"id":"https://openalex.org/S146641495","display_name":"JAMA Dermatology","issn_l":"2168-6068","issn":["2168-6068","2168-6084"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Dermatology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10483383","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028062574","display_name":"Yaxin Du","orcid":"https://orcid.org/0000-0001-7153-5924","observed_orcids":["https://orcid.org/0000-0001-7153-5924"]},"institutions":[{"id":"https://openalex.org/I4210105806","display_name":"Zhongda Hospital Southeast University","ror":"https://ror.org/01k3hq685","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210105806"]},{"id":"https://openalex.org/I76569877","display_name":"Southeast University","ror":"https://ror.org/04ct4d772","country_code":"CN","type":"education","lineage":["https://openalex.org/I76569877"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yaxin Du","raw_affiliation_strings":["Department of Dermatology, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China","institution_ids":["https://openalex.org/I4210105806","https://openalex.org/I76569877"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101892527","display_name":"Wenjie Wu","orcid":"https://orcid.org/0000-0001-7408-4401","observed_orcids":["https://orcid.org/0000-0001-7408-4401"]},"institutions":[{"id":"https://openalex.org/I4210105806","display_name":"Zhongda Hospital Southeast University","ror":"https://ror.org/01k3hq685","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210105806"]},{"id":"https://openalex.org/I76569877","display_name":"Southeast University","ror":"https://ror.org/04ct4d772","country_code":"CN","type":"education","lineage":["https://openalex.org/I76569877"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wenjie Wu","raw_affiliation_strings":["Department of Dermatology, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China","institution_ids":["https://openalex.org/I4210105806","https://openalex.org/I76569877"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100360830","display_name":"Mei Chen","orcid":"https://orcid.org/0000-0001-6809-147X","observed_orcids":["https://orcid.org/0000-0001-6809-147X"]},"institutions":[{"id":"https://openalex.org/I4210105806","display_name":"Zhongda Hospital Southeast University","ror":"https://ror.org/01k3hq685","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210105806"]},{"id":"https://openalex.org/I76569877","display_name":"Southeast University","ror":"https://ror.org/04ct4d772","country_code":"CN","type":"education","lineage":["https://openalex.org/I76569877"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Mei Chen","raw_affiliation_strings":["Department of Dermatology, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China","institution_ids":["https://openalex.org/I4210105806","https://openalex.org/I76569877"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041680182","display_name":"Zhengbang Dong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105806","display_name":"Zhongda Hospital Southeast University","ror":"https://ror.org/01k3hq685","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210105806"]},{"id":"https://openalex.org/I76569877","display_name":"Southeast University","ror":"https://ror.org/04ct4d772","country_code":"CN","type":"education","lineage":["https://openalex.org/I76569877"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhengbang Dong","raw_affiliation_strings":["Department of Dermatology, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China","institution_ids":["https://openalex.org/I4210105806","https://openalex.org/I76569877"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100455791","display_name":"Fei Wang","orcid":"https://orcid.org/0000-0002-1122-5286","observed_orcids":["https://orcid.org/0000-0002-1122-5286"]},"institutions":[{"id":"https://openalex.org/I4210105806","display_name":"Zhongda Hospital Southeast University","ror":"https://ror.org/01k3hq685","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210105806"]},{"id":"https://openalex.org/I76569877","display_name":"Southeast University","ror":"https://ror.org/04ct4d772","country_code":"CN","type":"education","lineage":["https://openalex.org/I76569877"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Fei Wang","raw_affiliation_strings":["Department of Dermatology, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, China","institution_ids":["https://openalex.org/I4210105806","https://openalex.org/I76569877"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5100455791"],"corresponding_institution_ids":["https://openalex.org/I4210105806","https://openalex.org/I76569877"],"apc_list":null,"apc_paid":null,"fwci":1.8941,"has_fulltext":false,"cited_by_count":56,"citation_normalized_percentile":{"value":0.89843105,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"159","issue":"10","first_page":"1093","last_page":"1093"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cutaneous-immune-related-adverse-events","display_name":"cutaneous immune-related adverse events","score":0.8999999761581421},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9950000047683716},{"id":"https://openalex.org/keywords/cancer-survival","display_name":"cancer survival","score":0.6370000243186951},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9169999957084656},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":1.0},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.5249999761581421},{"id":"https://openalex.org/keywords/cancer-prognosis","display_name":"cancer prognosis","score":0.5239999890327454},{"id":"https://openalex.org/keywords/cancer-types","display_name":"cancer types","score":0.7540000081062317},{"id":"https://openalex.org/keywords/geographic-region","display_name":"geographic region","score":0.5830000042915344},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.47200000286102295},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.5429999828338623},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-related-pneumonitis","display_name":"immune-related pneumonitis","score":0.5189999938011169},{"id":"https://openalex.org/keywords/immune-mediated-colitis","display_name":"immune-related colitis","score":0.7289999723434448},{"id":"https://openalex.org/keywords/immune-related-endocrinopathy","display_name":"immune-related endocrinopathy","score":0.6840000152587891},{"id":"https://openalex.org/keywords/immune-related-dermatitis","display_name":"immune-related dermatitis","score":0.609000027179718},{"id":"https://openalex.org/keywords/immune-related-encephalitis","display_name":"immune-related encephalitis","score":0.6809999942779541},{"id":"https://openalex.org/keywords/immune-related-hypophysitis","display_name":"immune-related hypophysitis","score":0.6370000243186951}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9010500907897949},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.6529300212860107},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6163733601570129},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.5649863481521606},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5323494076728821},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5241118669509888},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.5237117409706116},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4867410659790039},{"id":"https://openalex.org/C2776478404","wikidata":"https://www.wikidata.org/wiki/Q1105187","display_name":"Cochrane Library","level":3,"score":0.470551997423172},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.4515893757343292},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077982","descriptor_name":"Progression-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064887","descriptor_name":"Observational Studies as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1001/jamadermatol.2023.3003","doi":"https://doi.org/10.1001/jamadermatol.2023.3003","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jamadermatol.2023.3003","pdf_url":null,"source":{"id":"https://openalex.org/S146641495","display_name":"JAMA Dermatology","issn_l":"2168-6068","issn":["2168-6068","2168-6084"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Dermatology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10483383","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10483383","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Dermatol","raw_type":"Text"},{"id":"pmid:37672255","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37672255","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA dermatology","raw_type":"Meta-Analysis"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:10483383","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10483383","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Dermatol","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W2033585778","https://openalex.org/W2088095316","https://openalex.org/W2132916434","https://openalex.org/W2179179825","https://openalex.org/W2759963646","https://openalex.org/W2783137027","https://openalex.org/W2805602843","https://openalex.org/W2884284888","https://openalex.org/W2903486314","https://openalex.org/W2940771671","https://openalex.org/W2942467666","https://openalex.org/W2951610783","https://openalex.org/W2955135303","https://openalex.org/W2985481190","https://openalex.org/W2986118997","https://openalex.org/W2988124258","https://openalex.org/W3000305048","https://openalex.org/W3017217098","https://openalex.org/W3036354112","https://openalex.org/W3128782849","https://openalex.org/W3130288202","https://openalex.org/W3130731768","https://openalex.org/W3155812430","https://openalex.org/W3157675313","https://openalex.org/W3184010944","https://openalex.org/W3206014855","https://openalex.org/W4200385748","https://openalex.org/W4205572254","https://openalex.org/W4206083771","https://openalex.org/W4225128808","https://openalex.org/W4231329087","https://openalex.org/W4236862885","https://openalex.org/W4242624496","https://openalex.org/W4246422887","https://openalex.org/W4295564775","https://openalex.org/W4296162227","https://openalex.org/W4300960682","https://openalex.org/W4308407022","https://openalex.org/W4319038311","https://openalex.org/W6846259783"],"related_works":["https://openalex.org/W4415982085","https://openalex.org/W4406038226","https://openalex.org/W4319038311","https://openalex.org/W4391292945","https://openalex.org/W3137011630","https://openalex.org/W4414159623","https://openalex.org/W3115265739","https://openalex.org/W7202257162","https://openalex.org/W4319027050","https://openalex.org/W4390881707"],"abstract_inverted_index":{"Importance:":[0],"Growing":[1],"research":[2,118],"suggests":[3],"that":[4,115,371],"the":[5,33,67,109,120,161,171,234,238,315,338,349],"prevalence":[6],"of":[7,35,59,173,259,268,318,332,351],"cutaneous":[8],"immune-related":[9],"adverse":[10],"events":[11],"(cirAEs)":[12],"is":[13,44],"associated":[14,45,271,357],"with":[15,20,46,185,256,264,272,314,358,363],"favorable":[16],"outcomes":[17],"among":[18],"individuals":[19,362],"cancer":[21,48,77,126,224,311,364],"who":[22],"receive":[23],"immune":[24],"checkpoint":[25],"inhibitor":[26],"(ICI)":[27],"treatment.":[28,367,380],"Objective:":[29],"To":[30],"identify":[31],"whether":[32],"presence":[34,350],"cirAEs":[36,269,352,372],"and":[37,57,75,112,125,130,137,153,168,170,194,200,211,230,251,285,310,320,341,347,353],"their":[38,354],"subtypes":[39,355],"subsequent":[40,76,95],"to":[41,84,221],"ICI":[42,73,231,308,366,379],"administration":[43],"enhanced":[47],"prognosis.":[49,78,127],"Data":[50,128,187],"Sources:":[51],"The":[52,79,132,145,180,202,266],"PubMed,":[53],"Embase,":[54],"Cochrane":[55],"Library,":[56],"Web":[58],"Science":[60],"databases":[61],"were":[62,140,189,207,217,297,328],"searched":[63],"for":[64,165,361],"publications":[65,86],"examining":[66],"association":[68,121],"between":[69,122,191],"cirAE":[70,123,222],"development":[71,124],"during":[72],"treatment":[74],"initial":[80],"search":[81,96,133],"was":[82,97,182,245,270,356],"limited":[83],"English-language":[85],"from":[87],"database":[88],"inception":[89],"until":[90],"December":[91],"31,":[92],"2022;":[93],"a":[94,241,257],"performed":[98,149],"on":[99],"May":[100,192],"21,":[101],"2023.":[102,197],"Study":[103],"Selection:":[104],"Two":[105],"reviewers":[106,148],"independently":[107,152],"scrutinized":[108],"identical":[110],"articles":[111],"included":[113,239,253],"those":[114],"constituted":[116],"original":[117],"evaluating":[119],"Extraction":[129],"Synthesis:":[131],"terms,":[134],"study":[135,143,159,228,304],"objectives,":[136],"methodological":[138],"protocols":[139],"defined":[141],"before":[142],"initiation.":[144],"aforementioned":[146],"2":[147],"data":[150],"extraction":[151],"resolved":[154],"discrepancies":[155],"through":[156],"agreement.":[157],"This":[158,248],"followed":[160],"Preferred":[162],"Reporting":[163],"Items":[164],"Systematic":[166],"Reviews":[167],"Meta-analysis":[169,172],"Observational":[174],"Studies":[175],"in":[176,237,330,337,378],"Epidemiology":[177],"reporting":[178],"guidelines.":[179],"protocol":[181],"prospectively":[183],"registered":[184],"PROSPERO.":[186],"analyses":[188,216],"conducted":[190,219,336],"21":[193],"June":[195],"1,":[196],"Main":[198],"Outcomes":[199],"Measures:":[201],"major":[203],"outcome":[204],"end":[205],"points":[206],"overall":[208,316],"survival":[209,213],"(OS)":[210],"progression-free":[212],"(PFS).":[214],"Subgroup":[215],"also":[218],"according":[220],"type,":[223,225,309,312],"geographic":[226,306],"region,":[227,307],"design,":[229,305],"type.":[232],"Given":[233],"heterogeneity":[235],"inherent":[236],"studies,":[240],"DerSimonian-Laird":[242],"random-effects":[243],"model":[244],"adopted.":[246],"Results:":[247],"systematic":[249,345],"review":[250,346],"meta-analysis":[252],"23":[254],"studies":[255,335],"total":[258],"22":[260],"749":[261],"patients":[262],"treated":[263],"ICIs.":[265],"occurrence":[267],"improved":[273,359],"OS":[274,319],"(hazard":[275],"ratio":[276],"[HR],":[277],"0.61":[278],"[95%":[279,289],"CI,":[280,290],"0.52-0.72];":[281],"P":[282,292],"<":[283,293],".001)":[284],"PFS":[286,321,333],"(HR,":[287],"0.52":[288],"0.41-0.65];":[291],".001).":[294],"Consistent":[295],"results":[296],"observed":[298],"across":[299],"all":[300],"subgroups":[301],"stratified":[302],"by":[303],"aligning":[313],"estimate":[317],"improvement.":[322],"However,":[323],"no":[324],"statistically":[325],"significant":[326],"differences":[327],"identified":[329],"terms":[331],"within":[334],"US.":[339],"Conclusions":[340],"Relevance:":[342],"In":[343],"this":[344],"meta-analysis,":[348],"prognosis":[360],"undergoing":[365],"These":[368],"findings":[369],"suggest":[370],"may":[373],"have":[374],"useful":[375],"prognostic":[376],"value":[377]},"counts_by_year":[{"year":2026,"cited_by_count":24},{"year":2025,"cited_by_count":20},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2023-09-07T00:00:00"}